Neuphoria Therapeutics Inc. (NEUP) Financial Statements (2026 and earlier)

Company Profile

Business Address 100 SUMMIT DR
BURLINGTON, MA 01803
State of Incorp.
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
MRQ
6/30/2025
6/30/2024
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments22,17014,21112,608
Cash and cash equivalent22,17014,21112,608
Restricted cash and investments 80  
Receivables1,11012127
Prepaid expense27740459
Other undisclosed current assets  78 
Total current assets:23,38715,04113,194
Noncurrent Assets
Operating lease, right-of-use asset  103217
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization  32
Intangible asset, including goodwill, after accumulated amortization13,21113,44314,158
Goodwill8,7388,6398,690
Intangible asset, excluding goodwill, after accumulated amortization4,4734,8055,468
Restricted cash and investments   79
Total noncurrent assets:13,21113,54914,455
TOTAL ASSETS:36,59828,59027,649
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8112,2633,463
Accounts payable5211,1542,244
Accrued liabilities2901,1091,219
Other undisclosed current liabilities1,7761,958367
Total current liabilities:2,5864,2213,829
Noncurrent Liabilities
Liabilities, other than long-term debt1,5981,6651,672
Deferred income tax liabilities426495964
Other liabilities   3
Operating lease, liability   118
Business combination, contingent consideration, liability1,1731,170588
Other undisclosed noncurrent liabilities2,7133,7014,658
Total noncurrent liabilities:4,3115,3666,330
Total liabilities:6,8979,58710,159
Equity
Equity, attributable to parent29,70119,00317,490
Common stock00 
Additional paid in capital218,315200,194198,481
Accumulated other comprehensive loss(2,225)(2,845)(3,014)
Accumulated deficit(186,389)(178,347)(177,977)
Total equity:29,70119,00317,490
TOTAL LIABILITIES AND EQUITY:36,59828,59027,649

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
TTM
6/30/2025
6/30/2024
Revenues14,98715,649 
Gross profit:14,98715,649 
Operating expenses(18,558)(16,779)(17,892)
Operating loss:(3,571)(1,129)(17,892)
Nonoperating income (expense)(2,510)2912,313
Investment income, nonoperating409166220
Gain (loss), foreign currency transaction, before tax37  
Loss from continuing operations before income taxes:(6,081)(838)(15,579)
Income tax benefit41746887
Net loss available to common stockholders, basic:(5,664)(370)(15,492)
Dilutive securities, effect on basic earnings per share(5,379)  
Other undisclosed net income available to common stockholders, diluted2,770  
Net loss available to common stockholders, diluted:(8,273)(370)(15,492)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
TTM
6/30/2025
6/30/2024
Net loss:(5,664)(370)(15,492)
Other comprehensive income (loss)424(169)45
Other undisclosed comprehensive loss(169)  
Comprehensive loss:(5,408)(538)(15,447)
Other undisclosed comprehensive income, net of tax, attributable to parent1,236337 
Comprehensive loss, net of tax, attributable to parent:(4,173)(201)(15,447)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: